Back to Agenda
The Promise and Reality of Clinical Trial Transparency Initiatives
Session Chair(s)
Thomas Wicks, MBA
Head of Transparency Operations, Citeline, United States
The past decade has seen a virtual explosion of trial disclosure requirements and expectations around the world. This panel discussion will discuss the successes, challenges, and opportunities for improvement, looking back over the past ten years and forward to the expected developments in the next five.
Speaker(s)
Karla Childers, MS
Vice President, Bioethics, Policy & Partnerships, Johnson & Johnson, United States
Panel Discussion
Deborah Collyar
President, Patient Advocates In Research (PAIR), United States
Panel Discussion
Joao Ferreira, PHARMD
Clinical Data Publication Manager, European Medicines Agency, Netherlands
Panel Discussion
Sini Eskola, MPHARM, MS, MSC
Head of International Regulatory Policy and Innovation, Takeda, Belgium
Panel Discussion
Deborah Lincow
Associate, Bioethics International, United States
Panel Discussion
Have an account?